Warner Brent - Insider Non-Derivative Transactions at Poseida Therapeutics, Inc. (PSTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 1, 2024, Warner Brent's relationship to Poseida Therapeutics, Inc. (PSTX) is Officer (President, Gene Therapy), and currently has 454,779 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PSTX insiders.
Data Source: SEC.
Warner Brent - Insider Non-Derivative Transactions of PSTX Common Stock
Warner Brent - Insider Non-Derivative Transactions at PSTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 2, 2024 | F -- (Common Stock) | 35739 | 4.13 | 419040 |
| Mar 2, 2024 | Acquisition -- (Common Stock) | 80743 | 0 | 454779 |
| Mar 2, 2023 | F -- (Common Stock) | 26617 | 5.35 | 374036 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 92772 | 0 | 400653 |